IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role

OBJECTIVE: The interleukin 17 (IL-17) cytokine family is involved in a number of chronic inflammatory diseases. In spite of contradictory findings and a lack of causality in clinical studies, IL-17 inhibition for systemic lupus erythematosus (SLE) has regained attention as a potential therapeutic pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Rheumatol
Hlavní autoři: Raymond, Warren, Ostli-Eilertsen, Gro, Griffiths, Sheynae, Nossent, Johannes
Médium: Artigo
Jazyk:Inglês
Vydáno: Medical Research and Education Association 2017
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5335884/
https://ncbi.nlm.nih.gov/pubmed/28293450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16059
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky